Works by Kottschade, Lisa A.

Results: 43
    1

    Sex Differences in Tolerability to Anti‐Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non‐Small Cell Lung Cancer: Are We All Equal?

    Published in:
    Oncologist, 2019, v. 24, n. 11, p. e1148, doi. 10.1634/theoncologist.2019-0094
    By:
    • Duma, Narjust;
    • Abdel‐Ghani, Azzouqa;
    • Yadav, Siddhartha;
    • Hoversten, Katherine P.;
    • Reed, Clay T.;
    • Sitek, Andrea N.;
    • Enninga, Elizabeth Ann L.;
    • Paludo, Jonas;
    • Aguilera, Jesus Vera;
    • Leventakos, Konstantinos;
    • Lou, Yanyan;
    • Kottschade, Lisa A.;
    • Dong, Haidong;
    • Mansfield, Aaron S.;
    • Manochakian, Rami;
    • Adjei, Alex A.;
    • Dronca, Roxana S.
    Publication type:
    Article
    2

    A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.

    Published in:
    Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1279387
    By:
    • Smith, Katherine E. R.;
    • Kah-Whye Peng;
    • Pulido, Jose S.;
    • Weisbrod, Adam J.;
    • Strand, Carrie A.;
    • Allred, Jacob B.;
    • Newsom, Alysha N.;
    • Lianwen Zhang;
    • Packiriswamy, Nandakumar;
    • Kottke, Timothy;
    • Tonne, Jason M.;
    • Moore, Madelyn;
    • Montane, Heather N.;
    • Kottschade, Lisa A.;
    • McWilliams, Robert R.;
    • Dudek, Arkadiusz Z.;
    • Yiyi Yan;
    • Dimou, Anastasios;
    • Markovic, Svetomir N.;
    • Federspiel, Mark J.
    Publication type:
    Article
    3

    ASO Visual Abstract: Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-Institutional Cohort.

    Published in:
    2025
    By:
    • Montgomery, Kelsey B.;
    • Chandler McLeod, M.;
    • DePalo, Danielle K.;
    • Dugan, Michelle M.;
    • Zager, Jonathan S.;
    • Elleson, Kelly M.;
    • Sabel, Michael S.;
    • Hieken, Tina J.;
    • Kottschade, Lisa A.;
    • Ollila, David W.;
    • Pham, Veronica;
    • Archer, Dion;
    • Berman, Russell S.;
    • Lee, Ann Y.;
    • Cintolo-Gonzalez, Jessica A.;
    • McDonald, Hannah G.;
    • Winchester, Sydney;
    • Burke, Erin E.;
    • Rhodin, Kristen E.;
    • Beasley, Georgia M.
    Publication type:
    Abstract
    4

    Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-institutional Cohort.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2025, v. 32, n. 3, p. 1453, doi. 10.1245/s10434-024-16498-w
    By:
    • Montgomery, Kelsey B.;
    • McLeod, M. Chandler;
    • DePalo, Danielle K.;
    • Dugan, Michelle M.;
    • Zager, Jonathan S.;
    • Elleson, Kelly M.;
    • Sabel, Michael S.;
    • Hieken, Tina J.;
    • Kottschade, Lisa A.;
    • Ollila, David W.;
    • Pham, Veronica;
    • Archer, Dion;
    • Berman, Russell S.;
    • Lee, Ann Y.;
    • Cintolo-Gonzalez, Jessica A.;
    • McDonald, Hannah G.;
    • Winchester, Sydney;
    • Burke, Erin E.;
    • Rhodin, Kristen E.;
    • Beasley, Georgia M.
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11

    Sinonasal mucosal melanoma: An analysis of treatment‐related adverse events and associated factors.

    Published in:
    International Forum of Allergy & Rhinology, 2023, v. 13, n. 6, p. 1037, doi. 10.1002/alr.23118
    By:
    • Johnson, Brian J.;
    • Guo, Ruifeng;
    • Moore, Eric J.;
    • Price, Daniel L.;
    • Van Abel, Kathryn M.;
    • Van Gompel, Jamie J.;
    • Link, Michael J.;
    • Peris‐Celda, Maria;
    • Stokken, Janalee K.;
    • Pinheiro‐Neto, Carlos;
    • Kottschade, Lisa;
    • Markovic, Svetomir;
    • Block, Matthew;
    • McWilliams, Robert;
    • Montane, Heather;
    • Dimou, Anastasios;
    • Gergelis, Kimberly;
    • Gamez, Mauricio E.;
    • Choby, Garret
    Publication type:
    Article
    12

    Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations.

    Published in:
    PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0230306
    By:
    • DeLeon, Thomas T.;
    • Almquist, Daniel R.;
    • Kipp, Benjamin R.;
    • Langlais, Blake T.;
    • Mangold, Aaron;
    • Winters, Jennifer L.;
    • Kosiorek, Heidi E.;
    • Joseph, Richard W.;
    • Dronca, Roxana S.;
    • Block, Matthew S.;
    • McWilliams, Robert R.;
    • Kottschade, Lisa A.;
    • Rumilla, Kandelaria M.;
    • Voss, Jesse S.;
    • Seetharam, Mahesh;
    • Sekulic, Aleksandar;
    • Markovic, Svetomir N.;
    • Bryce, Alan H.
    Publication type:
    Article
    13
    14
    15
    16
    17

    Neoadjuvant systemic therapy for regionally advanced melanoma.

    Published in:
    Journal of Surgical Oncology, 2018, v. 117, n. 6, p. 1164, doi. 10.1002/jso.24939
    By:
    • Jakub, James W.;
    • Racz, Jennifer M.;
    • Hieken, Tina J.;
    • Gonzalez, Alexandra B.;
    • Kottschade, Lisa A.;
    • Markovic, Svetomir N.;
    • Yan, Yiyi;
    • Block, Mathew S.
    Publication type:
    Article
    18

    Levetiracetam for the treatment of hot flashes: a phase II study.

    Published in:
    2008
    By:
    • Thompson S;
    • Bardia A;
    • Tan A;
    • Barton DL;
    • Kottschade L;
    • Sloan JA;
    • Christensen B;
    • Smith D;
    • Loprinzi CL;
    • Thompson, Susan;
    • Bardia, Aditya;
    • Tan, Angelina;
    • Barton, Debra L;
    • Kottschade, Lisa;
    • Sloan, Jeff A;
    • Christensen, Brad;
    • Smith, DeAnne;
    • Loprinzi, Charles L
    Publication type:
    journal article
    19
    20

    Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45798-8
    By:
    • Hieken, Tina J.;
    • Nelson, Garth D.;
    • Flotte, Thomas J.;
    • Grewal, Eric P.;
    • Chen, Jun;
    • McWilliams, Robert R.;
    • Kottschade, Lisa A.;
    • Yang, Lu;
    • Domingo-Musibay, Evidio;
    • Dronca, Roxana S.;
    • Yan, Yiyi;
    • Markovic, Svetomir N.;
    • Dimou, Anastasios;
    • Montane, Heather N.;
    • Erskine, Courtney L.;
    • Piltin, Mara A.;
    • Price, Daniel L.;
    • Khariwala, Samir S.;
    • Hui, Jane;
    • Strand, Carrie A.
    Publication type:
    Article
    21

    Pilot Evaluation of Flaxseed for the Management of Hot Flashes.

    Published in:
    Journal of the Society for Integrative Oncology, 2007, v. 5, n. 3, p. 106, doi. 10.2310/7200.2007.007
    By:
    • Pruthi, Sandhya;
    • Thompson, Susan L.;
    • Novotny, Paul J.;
    • Barton, Debra L.;
    • Kottschade, Lisa A.;
    • Tan, Angelina D.;
    • Sloan, Jeff A.;
    • Loprinzi, Charles L.
    Publication type:
    Article
    22
    23
    24
    25
    26

    Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).

    Published in:
    2021
    By:
    • Broman, Kristy Kummerow;
    • Hughes, Tasha;
    • Dossett, Lesly;
    • Sun, James;
    • Kirichenko, Dennis;
    • Carr, Michael J.;
    • Sharma, Avinash;
    • Bartlett, Edmund K.;
    • Nijhuis, Amanda A. G.;
    • Thompson, John F.;
    • Hieken, Tina J.;
    • Kottschade, Lisa;
    • Downs, Jennifer;
    • Gyorki, David E.;
    • Stahlie, Emma;
    • Akkooi, Alexander;
    • Ollila, David W.;
    • Frank, Jill;
    • Song, Yun;
    • Karakousis, Giorgos
    Publication type:
    journal article
    27
    28

    Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance).

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 22, p. 3575, doi. 10.1002/cncr.28892
    By:
    • Barton, Debra L.;
    • Thanarajasingam, Gita;
    • Sloan, Jeff A.;
    • Diekmann, Brent;
    • Fuloria, Jyotsna;
    • Kottschade, Lisa A.;
    • Lyss, Alan P.;
    • Jaslowski, Anthony J.;
    • Mazurczak, Miroslaw A.;
    • Blair, Scott C.;
    • Terstriep, Shelby;
    • Loprinzi, Charles L.
    Publication type:
    Article
    29

    A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775.

    Published in:
    2013
    By:
    • Kottschade LA;
    • Suman VJ;
    • Perez DG;
    • McWilliams RR;
    • Kaur JS;
    • Amatruda TT 3rd;
    • Geoffroy FJ;
    • Gross HM;
    • Cohen PA;
    • Jaslowski AJ;
    • Kosel ML;
    • Markovic SN;
    • Kottschade, Lisa A;
    • Suman, Vera J;
    • Perez, Domingo G;
    • McWilliams, Robert R;
    • Kaur, Judith S;
    • Amatruda, Thomas T 3rd;
    • Geoffroy, Francois J;
    • Gross, Howard M
    Publication type:
    journal article
    30
    31

    A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group Study, N057E(1).

    Published in:
    2011
    By:
    • Kottschade LA;
    • Suman VJ;
    • Amatruda T 3rd;
    • McWilliams RR;
    • Mattar BI;
    • Nikcevich DA;
    • Behrens R;
    • Fitch TR;
    • Jaslowski AJ;
    • Markovic SN;
    • Kottschade, Lisa A;
    • Suman, Vera J;
    • Amatruda, Thomas 3rd;
    • McWilliams, Robert R;
    • Mattar, Bassam I;
    • Nikcevich, Daniel A;
    • Behrens, Robert;
    • Fitch, Tom R;
    • Jaslowski, Anthony J;
    • Markovic, Svetomir N
    Publication type:
    journal article
    32
    33

    Clinical characteristics, outcomes, and predictive modeling of patients diagnosed with immune checkpoint inhibitor therapy-related pneumonitis.

    Published in:
    Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04053-9
    By:
    • Hazim, Antonious;
    • Guiance, Irene Riestra;
    • Shreve, Jacob;
    • Ruan, Gordon;
    • McGlothlin, Damian;
    • LeMahieu, Allison;
    • Haemmerle, Robert;
    • Mcconn, Keith;
    • Godby, Richard C.;
    • Kottschade, Lisa;
    • Schwecke, Anna;
    • Fazer-Posorske, Casey;
    • Peikert, Tobias;
    • Edell, Eric;
    • Leventakos, Konstantinos;
    • Egan, Ashley
    Publication type:
    Article
    34
    35

    Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma.

    Published in:
    Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 1, p. 1, doi. 10.36401/JIPO-23-20
    By:
    • Sener, Ugur;
    • Webb, Mason;
    • Breen, William G.;
    • Neth, Bryan J.;
    • Laack, Nadia N.;
    • Routman, David;
    • Brown, Paul D.;
    • Mahajan, Anita;
    • Frechette, Kelsey;
    • Dudek, Arkadiusz Z.;
    • Markovic, Svetomir N.;
    • Block, Matthew S.;
    • McWilliams, Robert R.;
    • Dimou, Anastasios;
    • Kottschade, Lisa A.;
    • Montane, Heather N.;
    • Kizilbash, Sani H.;
    • Campian, Jian L.
    Publication type:
    Article
    36
    37
    38

    Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial.

    Published in:
    2022
    By:
    • Basch, Ethan;
    • Schrag, Deborah;
    • Henson, Sydney;
    • Jansen, Jennifer;
    • Ginos, Brenda;
    • Stover, Angela M.;
    • Carr, Philip;
    • Spears, Patricia A.;
    • Jonsson, Mattias;
    • Deal, Allison M.;
    • Bennett, Antonia V.;
    • Thanarajasingam, Gita;
    • Rogak, Lauren J.;
    • Reeve, Bryce B.;
    • Snyder, Claire;
    • Bruner, Deborah;
    • Cella, David;
    • Kottschade, Lisa A.;
    • Perlmutter, Jane;
    • Geoghegan, Cindy
    Publication type:
    journal article
    39
    40
    41

    In-Transit Melanoma: An Individualized Approach.

    Published in:
    Oncology (08909091), 2011, v. 25, n. 14, p. 1340
    By:
    • GROTZ, TRAVIS E.;
    • MANSFIELD, AARON S.;
    • KOTTSCHADE, LISA A.;
    • ERICKSON, LORI A.;
    • OTLEY, CLARK C.;
    • MARKOVIC, SVETOMIR N.;
    • JAKUB, JAMES W.
    Publication type:
    Article
    42
    43

    Combination of paclitaxel and carboplatin as second‐line therapy for patients with metastatic melanomaData previously presented at the annual meeting of the American Society of Clinical Oncology, Orlando, Florida, May 13–17, 2005.Institutional review board (IRB) permission was obtained for this analysis. The medical records of patients who refused research authorization were excluded from our study.

    Published in:
    Cancer (0008543X), 2006, v. 106, n. 2, p. 375
    By:
    • Ravi D. Rao;
    • Shernan G. Holtan;
    • James N. Ingle;
    • Gary A. Croghan;
    • Lisa A. Kottschade;
    • Edward T. Creagan;
    • Judith S. Kaur;
    • Henry C. Pitot;
    • Svetomir N. Markovic
    Publication type:
    Article